The GMDN Agency have provided the summary information below. This is regarding a consultation on specific IVD related GMDN terms.
The IVD Team at the GMDN Agency have launched a consultation regarding a proposed scaling back of antibody-specific IVD terms within the GMDN. The move would be to consolidate all infectious disease antibody-class specific terms for a particular analyte to a single concept, including total antibody and neutralizing antibody concepts.
This means the distinction between IgA, IgM, and IgG and any combination thereof would be removed, leaving a broader single concept. We hope this change will make the identification of the correct GMDN Term easier with less opportunity for mis-assignment.
The consultation is open until the 29 of November 2021 at 16:00hrs GMT.
What do I need to do?
Please provide feedback by 25 November 2021 to Ashleigh Batchen, email@example.com. BIVDA will then provide a response to the GMDN on member’s behalf.